GlassScriptPhysician profile
Eric D Swisher
NPI 1720002868
$3,963.40
in general payments reported to CMS, 2019-2025
29 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $2,029 · 2021: $25.15 · 2022: $294 · 2023: $634 · 2024: $338 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,963.69 | 2020 | |
| Abbvie INC. | $371.31 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $227.06 | 2019-2025 | |
| Astellas Pharma US INC | $223.11 | 2022-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $205.24 | 2023-2025 | Gemtesa, Myfembree |
| Organon LLC | $127.59 | 2023-2025 | Nexplanon |
| Amgen INC. | $107.26 | 2019-2025 | Evenity, Prolia |
| Biogen, INC. | $98.24 | 2024-2025 | Zurzuvae |
| Tactile Systems Technology INC | $56.17 | 2022 | |
| Coopersurgical, INC. | $50.62 | 2021-2023 | Endosee |
| Hologic Sales and Service, LLC | $50.17 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Vertex Pharmaceuticals Incorporated | $47.78 | 2024-2025 | |
| Exeltis, USA INC. | $46.55 | 2023-2024 | Nuvessa, Slynd |
| Urovant Sciences INC | $45.41 | 2022 | |
| Merck Sharp & Dohme LLC | $39.70 | 2020-2023 | Gardasil 9 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $36.13 | 2019 | |
| Pfizer INC. | $32.99 | 2023-2024 | |
| Minerva Surgical, INC | $32.09 | 2024 | |
| Coloplast Corp | $28.59 | 2025 | |
| Davol INC. | $23.30 | 2025 | Arista |
| Dexcom, INC. | $22.37 | 2023 | Dexcom G6 Transmitter |
| Aspira Women'S Health INC | $18.47 | 2023 | Ova1 |
| Mayne Pharma Commercial LLC | $17.85 | 2023 | |
| Myovant Sciences INC. | $16.21 | 2022 | |
| Lilly USA, LLC | $16.12 | 2025 | Zepbound |
| Si-Bone, INC. | $16.04 | 2024 | |
| Abbott Laboratories | $15.98 | 2023 | Proclaim |
| Baxter Healthcare | $15.83 | 2024 | Perclot |
| Novo Nordisk INC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Swisher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.